{"schema_version":"secwatch.filing_event.v1","accession":"0001568651-24-000013","form_type":"8-K","ticker":"OSCR","cik":"0001568651","company_name":"Oscar Health, Inc.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.009780+00:00","generated_at":"2026-06-02T18:20:54.957872+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Oscar Health reports first-ever quarterly net income of $177.4M; revenue up 46% YoY","bullets":["Q1 2024 net income of $177.4M ($0.62 diluted EPS) vs. net loss of $39.8M in Q1 2023.","Total revenue of $2.1B, up 46% YoY driven by higher membership and pricing.","Medical Loss Ratio improved 210 bps YoY to 74.2%; SG&A Expense Ratio improved 870 bps to 18.4%.","Adjusted EBITDA of $219.3M, up $168.2M YoY; total members reached 1,448,408.","Company reaffirms full-year 2024 outlook across all metrics."],"urls":{"canonical":"https://secwatch.observer/filing/0001568651-24-000013","json":"https://secwatch.observer/filing/0001568651-24-000013.json","markdown":"https://secwatch.observer/filing/0001568651-24-000013.md","text":"https://secwatch.observer/filing/0001568651-24-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1568651/000156865124000013/0001568651-24-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1568651/000156865124000013/oscr-20240507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T18:20:54.957872+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f829e502171c1e03ccee401a83b950e963cc7c10","claim":"Oscar Health, Inc. reported First Quarter 2024 results: revenue $2.1 billion, net income $177.4 million, EPS $0.62. Guidance reaffirmed.","evidence_excerpt":"Oscar Health, Inc. ir.hioscar.com News Release Oscar Health Announces Results for First Quarter 2024 May 7, 2024 • For the quarter ended March 31, 2024: ◦ Total Revenue of $2.1 billion, a 46% increase YoY ◦ Medical Loss Ratio of 74.2%, a 210 bps improvement YoY ◦ SG&A Expense Ratio of 18.4%, an 870 bps improvement YoY ◦ Net Income attributable to Oscar of $177.4 million, or $0.62 of diluted earnings per share, a $217.1 million improvement YoY","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1568651/000156865124000013/0001568651-24-000013-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"First Quarter 2024"},{"label":"Revenue","value":"$2.1 billion"},{"label":"Net income","value":"$177.4 million"},{"label":"EPS","value":"$0.62"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}